Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alembic Pharmaceuticals
Pharma
Alembic site hit with warning letter on patient consent concerns
After a March inspection yielded a Form 483, Indian generics juggernaut Alembic has received a harsher reprimand from the FDA.
Fraiser Kansteiner
Jul 21, 2026 11:40am
J&J-Fujifilm, drug recalls, RemeGen-Santen—Fierce Pharma Asia
Aug 22, 2025 8:05am
Alembic, Sun and Glenmark issue recalls due to production issues
Aug 20, 2025 9:40am
Breaking down Iterum's UTI antibiotic launch in the US
Aug 20, 2025 8:01am
Flooding halts manufacturing at Alembic Pharmaceuticals plant
Oct 5, 2023 8:45am
Moderna, GSK and Glenmark—Fierce Pharma Asia
Aug 25, 2023 9:20am
